Murillo's-bark
Quillaja saponaria
昆尼亚皂荚（又称肥皂树）起源于南美洲，在传统医学中有着悠久的历史。传统上，由于其含有皂苷，其提取物被用于清洁用途，但具体的传统医疗用途并未得到充分记录。 科学证据主要强调了昆尼亚皂荚活性成分的潜力，特别是QS-21在疫苗佐剂和微生物生产策略中的应用。研究表明，QS-21可以引发强烈的T细胞反应，并为某些病原体（如日本脑炎病毒JEV）提供保护性免疫，在小鼠中表现出良好的效果。然而，目前的证据主要限于动物模型和早期临床试验。 昆尼亚皂荚的安全性表现良好，未记录到重大问题。没有报告药物相互作用，这表明它在单独使用或与其他物质组合时可能不会引起显著不良反应。不过，还需要进一步研究以全面了解其在不同人群和应用中的安全性。
- 最佳证据
- D
- 注意事项
- —
仅供参考。传统用法并不代表已被证实有效。证据与安全性各不相同，请查阅所引来源。
科学怎么说
- 该研究回顾了QS皂苷的生物合成，特别是QS-21，强调其在疫苗佐剂和微生物生产策略中的潜在应用。
- 该研究开发了一种使用HPLC-QToF-MS的测试方法来确认禽类饲料中是否存在Quillaja皂苷，并检测到Madhuca皂苷掺假。
- 由CoPoP介导的颗粒化与QS-21刺激结合，在小鼠中引发了强大的T细胞反应并提供了对JEV挑战的保护性免疫。
- 研究表明，尽管野生收获可以支持千克规模的QS-21纯化，克隆造林可能是满足日益增长的佐剂需求最实用和可扩展的战略。
Frequently asked questions
What is Murillo's-bark?
Murillo's-bark (Quillaja saponaria) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Murillo's-bark?
4 sourced findings are recorded for Murillo's-bark; the strongest carries evidence grade D. For example: 该研究回顾了QS皂苷的生物合成，特别是QS-21，强调其在疫苗佐剂和微生物生产策略中的潜在应用。
How strong is the evidence for Murillo's-bark?
The strongest finding for Murillo's-bark carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Murillo's-bark safe? What are the side effects?
No major safety issues are recorded for Murillo's-bark in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Murillo's-bark interact with medications?
No drug interactions are recorded for Murillo's-bark in our sources. This does not rule them out — check with a pharmacist.
What are the common names of Murillo's-bark?
Murillo's-bark is also known as: Квиллайя мыльная.
Is Murillo's-bark a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
来源
- T2 The challenge of one billion adjuvanted vaccine doses: evaluating scalability, sustainability, and supply capacity of Quillaja saponin QS-21 for large-scale vaccine demand. literature abstract metadata
- T2 Recombinant Japanese Encephalitis Virus Envelope Antigen Presented on CoPoP Liposomes Elicits Cellular Immunity and Protects Mice From Lethal Challenge. literature abstract metadata
- T2 Advances in the heterologous biosynthesis of QS saponins: a review. literature abstract metadata
- T2 A confirmation test for the presence of Quillaja saponin and adulteration with Madhuca saponin in poultry feed using high-performance liquid chromatography and quadrupole time-of-flight mass spectrometry. literature abstract metadata